Janet Rose Rea
Geschäftsführer bei Ave Maria Biotechnology LLC
Profil
Janet Rose Rea is currently the Chief Operating Officer at Ave Maria Biotechnology LLC.
Previously, she worked as the VP-Regulatory Affairs, Quality & Clinical Affairs at Atossa Therapeutics, Inc. from 2015 to 2020.
She also served as an Assistant Clinical Professor at the University of Washington.
Ms. Rea completed her undergraduate and graduate degrees at the University of Washington.
Aktive Positionen von Janet Rose Rea
| Unternehmen | Position | Beginn |
|---|---|---|
Ave Maria Biotechnology LLC
 Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Geschäftsführer | 08.07.2020 |
Ehemalige bekannte Positionen von Janet Rose Rea
| Unternehmen | Position | Ende |
|---|---|---|
| ATOSSA THERAPEUTICS, INC. | General Counsel | 01.07.2020 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Ausbildung von Janet Rose Rea
| University of Washington | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ave Maria Biotechnology LLC
Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA. | Commercial Services |